Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31066836 | 1.00 | STING1 (0.55) | STING1TBK1 | |
| SCHEMBL23855739 | 1.00 | STING1 (0.55) | STING1TBK1 | |
| SCHEMBL21753391 | 1.00 | STING1 (0.55) | STING1TBK1 | |
| SCHEMBL21753393 | 0.95 | STING1 (0.54) | STING1TBK1 | |
| SCHEMBL22110044 | 0.94 | STING1 (0.56) | STING1TBK1 | |
| SCHEMBL22109889 | 0.94 | STING1 (0.56) | STING1TBK1 | |
| SCHEMBL21789991 | 0.92 | STING1 (0.58) | STING1TBK1 | |
| SCHEMBL21766168 | 0.92 | STING1 (0.58) | STING1TBK1 | |
| SCHEMBL21789632 | 0.92 | STING1 (0.58) | STING1TBK1 | |
| SCHEMBL23318682 | 0.92 | STING1 (0.56) | STING1TBK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3842437-B1 | HIGH ACTIVITY STING PROTEIN AGONIST | ADLAI NORTYE BIOPHARMA CO LTD (CN) | 2024-04-10 | — | — | EP | disclosed |
| CN-112661772-B | Interferon gene stimulating protein compound and preparation method thereof | 杭州阿诺生物医药科技有限公司 | 2022-06-10 | — | — | CN | disclosed |
| EP-3842437-A1 | HIGH ACTIVITY STING PROTEIN AGONIST | Adlai Nortye Biopharma Co., Ltd. (CN) | 2021-06-30 | — | — | EP | disclosed |
| CN-111386275-A | High activity STING protein agonists | 杭州阿诺生物医药科技有限公司 | 2020-07-07 | — | — | CN | disclosed |
| WO-2020038387-A1 | HIGH ACTIVITY STING PROTEIN AGONIST | 杭州阿诺生物医药科技有限公司 | 2020-02-27 | — | — | WO | disclosed |